Cargando…
TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p
Recent evidence suggests that the ion channel TRPA1 is implicated in lung adenocarcinoma (LUAD), where its role and mechanism of action remain unknown. We have previously established that the membrane receptor FGFR2 drives LUAD progression through aberrant protein–protein interactions mediated via i...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643494/ https://www.ncbi.nlm.nih.gov/pubmed/29038531 http://dx.doi.org/10.1038/s41467-017-00983-w |
_version_ | 1783271542266789888 |
---|---|
author | Berrout, Jonathan Kyriakopoulou, Eleni Moparthi, Lavanya Hogea, Alexandra S. Berrout, Liza Ivan, Cristina Lorger, Mihaela Boyle, John Peers, Chris Muench, Stephen Gomez, Jacobo Elies Hu, Xin Hurst, Carolyn Hall, Thomas Umamaheswaran, Sujanitha Wesley, Laura Gagea, Mihai Shires, Michael Manfield, Iain Knowles, Margaret A. Davies, Simon Suhling, Klaus Gonzalez, Yurema Teijeiro Carragher, Neil Macleod, Kenneth Abbott, N. Joan Calin, George A. Gamper, Nikita Zygmunt, Peter M. Timsah, Zahra |
author_facet | Berrout, Jonathan Kyriakopoulou, Eleni Moparthi, Lavanya Hogea, Alexandra S. Berrout, Liza Ivan, Cristina Lorger, Mihaela Boyle, John Peers, Chris Muench, Stephen Gomez, Jacobo Elies Hu, Xin Hurst, Carolyn Hall, Thomas Umamaheswaran, Sujanitha Wesley, Laura Gagea, Mihai Shires, Michael Manfield, Iain Knowles, Margaret A. Davies, Simon Suhling, Klaus Gonzalez, Yurema Teijeiro Carragher, Neil Macleod, Kenneth Abbott, N. Joan Calin, George A. Gamper, Nikita Zygmunt, Peter M. Timsah, Zahra |
author_sort | Berrout, Jonathan |
collection | PubMed |
description | Recent evidence suggests that the ion channel TRPA1 is implicated in lung adenocarcinoma (LUAD), where its role and mechanism of action remain unknown. We have previously established that the membrane receptor FGFR2 drives LUAD progression through aberrant protein–protein interactions mediated via its C-terminal proline-rich motif. Here we report that the N-terminal ankyrin repeats of TRPA1 directly bind to the C-terminal proline-rich motif of FGFR2 inducing the constitutive activation of the receptor, thereby prompting LUAD progression and metastasis. Furthermore, we show that upon metastasis to the brain, TRPA1 gets depleted, an effect triggered by the transfer of TRPA1-targeting exosomal microRNA (miRNA-142-3p) from brain astrocytes to cancer cells. This downregulation, in turn, inhibits TRPA1-mediated activation of FGFR2, hindering the metastatic process. Our study reveals a direct binding event and characterizes the role of TRPA1 ankyrin repeats in regulating FGFR2-driven oncogenic process; a mechanism that is hindered by miRNA-142-3p. |
format | Online Article Text |
id | pubmed-5643494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-56434942017-10-18 TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p Berrout, Jonathan Kyriakopoulou, Eleni Moparthi, Lavanya Hogea, Alexandra S. Berrout, Liza Ivan, Cristina Lorger, Mihaela Boyle, John Peers, Chris Muench, Stephen Gomez, Jacobo Elies Hu, Xin Hurst, Carolyn Hall, Thomas Umamaheswaran, Sujanitha Wesley, Laura Gagea, Mihai Shires, Michael Manfield, Iain Knowles, Margaret A. Davies, Simon Suhling, Klaus Gonzalez, Yurema Teijeiro Carragher, Neil Macleod, Kenneth Abbott, N. Joan Calin, George A. Gamper, Nikita Zygmunt, Peter M. Timsah, Zahra Nat Commun Article Recent evidence suggests that the ion channel TRPA1 is implicated in lung adenocarcinoma (LUAD), where its role and mechanism of action remain unknown. We have previously established that the membrane receptor FGFR2 drives LUAD progression through aberrant protein–protein interactions mediated via its C-terminal proline-rich motif. Here we report that the N-terminal ankyrin repeats of TRPA1 directly bind to the C-terminal proline-rich motif of FGFR2 inducing the constitutive activation of the receptor, thereby prompting LUAD progression and metastasis. Furthermore, we show that upon metastasis to the brain, TRPA1 gets depleted, an effect triggered by the transfer of TRPA1-targeting exosomal microRNA (miRNA-142-3p) from brain astrocytes to cancer cells. This downregulation, in turn, inhibits TRPA1-mediated activation of FGFR2, hindering the metastatic process. Our study reveals a direct binding event and characterizes the role of TRPA1 ankyrin repeats in regulating FGFR2-driven oncogenic process; a mechanism that is hindered by miRNA-142-3p. Nature Publishing Group UK 2017-10-16 /pmc/articles/PMC5643494/ /pubmed/29038531 http://dx.doi.org/10.1038/s41467-017-00983-w Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Berrout, Jonathan Kyriakopoulou, Eleni Moparthi, Lavanya Hogea, Alexandra S. Berrout, Liza Ivan, Cristina Lorger, Mihaela Boyle, John Peers, Chris Muench, Stephen Gomez, Jacobo Elies Hu, Xin Hurst, Carolyn Hall, Thomas Umamaheswaran, Sujanitha Wesley, Laura Gagea, Mihai Shires, Michael Manfield, Iain Knowles, Margaret A. Davies, Simon Suhling, Klaus Gonzalez, Yurema Teijeiro Carragher, Neil Macleod, Kenneth Abbott, N. Joan Calin, George A. Gamper, Nikita Zygmunt, Peter M. Timsah, Zahra TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p |
title | TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p |
title_full | TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p |
title_fullStr | TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p |
title_full_unstemmed | TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p |
title_short | TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p |
title_sort | trpa1–fgfr2 binding event is a regulatory oncogenic driver modulated by mirna-142-3p |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643494/ https://www.ncbi.nlm.nih.gov/pubmed/29038531 http://dx.doi.org/10.1038/s41467-017-00983-w |
work_keys_str_mv | AT berroutjonathan trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT kyriakopouloueleni trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT moparthilavanya trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT hogeaalexandras trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT berroutliza trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT ivancristina trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT lorgermihaela trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT boylejohn trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT peerschris trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT muenchstephen trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT gomezjacoboelies trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT huxin trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT hurstcarolyn trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT hallthomas trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT umamaheswaransujanitha trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT wesleylaura trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT gageamihai trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT shiresmichael trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT manfieldiain trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT knowlesmargareta trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT daviessimon trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT suhlingklaus trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT gonzalezyuremateijeiro trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT carragherneil trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT macleodkenneth trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT abbottnjoan trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT calingeorgea trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT gampernikita trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT zygmuntpeterm trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p AT timsahzahra trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p |